首页> Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology> Radiotherapy for prostate cancer - Does daily image guidance with tighter margins improve patient reported outcomes compared to weekly orthogonal verified irradiation? Results from a randomized controlled trial.

Radiotherapy for prostate cancer - Does daily image guidance with tighter margins improve patient reported outcomes compared to weekly orthogonal verified irradiation? Results from a randomized controlled trial.

导出原文传递

翻译打印收藏纠错

第一作者： Hanne,Tøndel

第一单位： Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Norway; Department of Cancer Research and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology Trondheim, Norway. Electronic address: hanne.tondel@ntnu.no.

作者： Hanne,Tøndel ^[1] ; Jo-Åsmund,Lund ^[2] ; Stian,Lydersen ^[3] ; Anne D,Wanderås ^[4] ; Bjørg,Aksnessæther ^[5] ; Christer Andre,Jensen ^[5] ; Stein,Kaasa ^[6] ; Arne,Solberg ^[7]

作者单位： Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Norway; Department of Cancer Research and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology Trondheim, Norway. Electronic address: hanne.tondel@ntnu.no. ^[1] Department of Cancer Research and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology Trondheim, Norway; Helse Møre and Romsdal, Ålesund, Norway. ^[2] Regional Centre for Child and Youth Mental Health and Child Welfare, Department of Mental Health, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway. ^[3] Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Norway. ^[4] Helse Møre and Romsdal, Ålesund, Norway. ^[5] Department of Cancer Research and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology Trondheim, Norway; Department of Oncology, Oslo University Hospital and University of Oslo, Norway; European Palliative Care Research Centre (PRC), Department of Cancer Research and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology and St. Olavs Hospital, Trondheim University Hospital, Norway. ^[6] Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Norway; Department of Cancer Research and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology Trondheim, Norway. ^[7]

关键词 IGRT Phase III trial Prostate cancer RCT Radiotherapy Rectal side effects